Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies
about
Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Mericitabine and Either Bocepr ...... DYNAMO 1 and DYNAMO 2 Studies
@ast
Mericitabine and Either Bocepr ...... DYNAMO 1 and DYNAMO 2 Studies
@en
Mericitabine and Either Bocepr ...... DYNAMO 1 and DYNAMO 2 Studies
@nl
type
label
Mericitabine and Either Bocepr ...... DYNAMO 1 and DYNAMO 2 Studies
@ast
Mericitabine and Either Bocepr ...... DYNAMO 1 and DYNAMO 2 Studies
@en
Mericitabine and Either Bocepr ...... DYNAMO 1 and DYNAMO 2 Studies
@nl
prefLabel
Mericitabine and Either Bocepr ...... DYNAMO 1 and DYNAMO 2 Studies
@ast
Mericitabine and Either Bocepr ...... DYNAMO 1 and DYNAMO 2 Studies
@en
Mericitabine and Either Bocepr ...... DYNAMO 1 and DYNAMO 2 Studies
@nl
P2093
P2860
P1433
P1476
Mericitabine and Either Bocepr ...... DYNAMO 1 and DYNAMO 2 Studies
@en
P2093
Astrid Scalori
Athina Voulgari
Christophe Hézode
Heiner Wedemeyer
Isabel Nájera
James A Thommes
Samuel S Lee
Sophie Le Pogam
Xavier Forns
P2860
P304
P356
10.1371/JOURNAL.PONE.0145409
P407
P577
2016-01-11T00:00:00Z